Urinary and Genital Oncology Studies
Urinary and Genital Oncology Studies is a research topic within Surgery. Science Explorer counts 25k research works in it since 1950. 13.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the clinical and pathological aspects of urachal carcinoma, including its diagnosis, management, and molecular characteristics. It also covers related topics such as primary urethral carcinoma, nephrogenic adenoma, bladder diverticulum, and immunohistochemical markers for differential diagnosis.
- Urachal Carcinoma
- Primary Urethral Carcinoma
- Nephrogenic Adenoma
- Bladder Diverticulum
- Immunohistochemical Markers
- Bartholin Gland Cyst
- Urethral Diverticulum
- Clear Cell Adenocarcinoma
- Metastatic Tumors
- Urothelial Origin
- Research works
- 25k fractional, since 1950
- In the world top 10%
- 3.4k per year above
- Top-10% rate
- 13.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +23% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Urinary and Genital Oncology Studies research?
By volume, the United States and China publish the most (781 and 529 works in 2022–2025).
By volume, 2022–2025
- 1 United States 781 works
- 2 China 529 works
- 3 India 301 works
- 4 Japan 261 works
- 5 Germany 171 works
- 6 Italy 154 works
- 7 United Kingdom 134 works
- 8 France 104 works
- 9 Türkiye 96 works
- 10 Spain 90 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Urinary and Genital Oncology Studies research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Urinary and Genital Oncology Studies research, followed by Memorial Sloan Kettering Cancer Center and All India Institute of Medical Sciences.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 21 works
- 2 Memorial Sloan Kettering Cancer CenterUnited States 18 works
- 3 All India Institute of Medical SciencesIndia 17 works
- 4 Sichuan UniversityChina 15 works
- 5 University of Southern CaliforniaUnited States 14 works
- 6 Peking UniversityChina 14 works
- 7 Icahn School of Medicine at Mount SinaiUnited States 13 works
- 8 Cleveland ClinicUnited States 13 works
- 9 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 12 works
- 10 Istituti di Ricovero e Cura a Carattere ScientificoItaly 12 works
Who are the leading researchers in Urinary and Genital Oncology Studies?
The most-cited researchers publishing on Urinary and Genital Oncology Studies include Kai Wang and Fred Saad.
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Urinary and Genital Oncology Studies research done?
The largest centres of Urinary and Genital Oncology Studies research in 2022–2025 are Beijing (China), New York (United States), Tokyo (Japan) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Cleveland.
Largest cities, 2022–2025
Where it is the local speciality
- ClevelandUS · 25.6 works4.9×
Location quotient: how much more of its research is in Urinary and Genital Oncology Studies than the world average.
Where is the best place to study Urinary and Genital Oncology Studies?
Among universities, judged by research, Medical University of Vienna, Vita-Salute San Raffaele University and Icahn School of Medicine at Mount Sinai score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Medical University of ViennaAustria | 72.0 | 23.9% | 9.9× | 11 | +182.9% |
| 2 | Vita-Salute San Raffaele UniversityItaly | 63.6 | 34.9% | 20.8× | 10 | -17.0% |
| 3 | Icahn School of Medicine at Mount SinaiUnited States | 61.4 | 25.2% | 7.5× | 13 | +136.0% |
| 4 | University of IowaUnited States | 48.1 | 33.1% | 6.5× | 10 | +11.6% |
| 5 | University of Southern CaliforniaUnited States | 45.3 | 25.6% | 5.3× | 14 | -18.8% |
| 6 | Cornell UniversityUnited States | 43.3 | 38.1% | 2.9× | 11 | -22.3% |
| 7 | Institute of Medical SciencesIndia | 39.4 | 10.3% | 7.7× | 9 | +165.6% |
| 8 | Johns Hopkins UniversityUnited States | 39.0 | 26.6% | 2.7× | 10 | +65.0% |
| 9 | All India Institute of Medical SciencesIndia | 38.3 | 5.9% | 7.6× | 17 | +4.2% |
| 10 | Peking UniversityChina | 36.6 | 13.7% | 2.5× | 14 | +107.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Urinary and Genital Oncology Studies research growing?
Output in 2018–2022 was 23% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Urinary and Genital Oncology Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.